vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and LINDSAY CORP (LNN). Click either name above to swap in a different company.

LINDSAY CORP is the larger business by last-quarter revenue ($150.7M vs $121.8M, roughly 1.2× Core Laboratories Inc.). LINDSAY CORP runs the higher net margin — 11.0% vs 4.2%, a 6.8% gap on every dollar of revenue. On growth, Core Laboratories Inc. posted the faster year-over-year revenue change (-1.4% vs -6.1%). Core Laboratories Inc. produced more free cash flow last quarter ($517.0K vs $-15.1M). Over the past eight quarters, LINDSAY CORP's revenue compounded faster (1.3% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Lindsay Corporation, formerly known as Lindsay Manufacturing Co., is a manufacturer of Zimmatic brand center pivot irrigation systems, based in Omaha, Nebraska, United States. It also manufactures farm and construction machinery, as well as road and railroad infrastructure equipment. At August 31, 2008, the company had 1,239 employees.

CLB vs LNN — Head-to-Head

Bigger by revenue
LNN
LNN
1.2× larger
LNN
$150.7M
$121.8M
CLB
Growing faster (revenue YoY)
CLB
CLB
+4.7% gap
CLB
-1.4%
-6.1%
LNN
Higher net margin
LNN
LNN
6.8% more per $
LNN
11.0%
4.2%
CLB
More free cash flow
CLB
CLB
$15.6M more FCF
CLB
$517.0K
$-15.1M
LNN
Faster 2-yr revenue CAGR
LNN
LNN
Annualised
LNN
1.3%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLB
CLB
LNN
LNN
Revenue
$121.8M
$150.7M
Net Profit
$5.1M
$16.5M
Gross Margin
33.3%
Operating Margin
1.5%
13.0%
Net Margin
4.2%
11.0%
Revenue YoY
-1.4%
-6.1%
Net Profit YoY
-3.7%
EPS (diluted)
$0.11
$1.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
LNN
LNN
Q1 26
$121.8M
Q4 25
$138.3M
$150.7M
Q3 25
$134.5M
$149.0M
Q2 25
$130.2M
$165.7M
Q1 25
$123.6M
$183.8M
Q4 24
$129.2M
$160.5M
Q3 24
$134.4M
$149.4M
Q2 24
$130.6M
$133.7M
Net Profit
CLB
CLB
LNN
LNN
Q1 26
$5.1M
Q4 25
$4.9M
$16.5M
Q3 25
$14.2M
$10.8M
Q2 25
$10.6M
$19.5M
Q1 25
$-154.0K
$26.6M
Q4 24
$7.4M
$17.2M
Q3 24
$11.7M
$12.7M
Q2 24
$9.0M
$20.4M
Gross Margin
CLB
CLB
LNN
LNN
Q1 26
Q4 25
20.8%
33.3%
Q3 25
22.0%
30.0%
Q2 25
20.3%
32.4%
Q1 25
19.5%
34.0%
Q4 24
17.8%
31.1%
Q3 24
20.5%
30.6%
Q2 24
21.2%
34.8%
Operating Margin
CLB
CLB
LNN
LNN
Q1 26
1.5%
Q4 25
11.5%
13.0%
Q3 25
15.6%
7.6%
Q2 25
11.7%
14.4%
Q1 25
3.6%
17.5%
Q4 24
11.0%
13.0%
Q3 24
14.7%
9.0%
Q2 24
12.3%
14.9%
Net Margin
CLB
CLB
LNN
LNN
Q1 26
4.2%
Q4 25
3.6%
11.0%
Q3 25
10.6%
7.3%
Q2 25
8.2%
11.8%
Q1 25
-0.1%
14.5%
Q4 24
5.7%
10.7%
Q3 24
8.7%
8.5%
Q2 24
6.9%
15.2%
EPS (diluted)
CLB
CLB
LNN
LNN
Q1 26
$0.11
Q4 25
$0.11
$1.54
Q3 25
$0.30
$0.99
Q2 25
$0.22
$1.78
Q1 25
$0.00
$2.44
Q4 24
$0.15
$1.57
Q3 24
$0.25
$1.16
Q2 24
$0.19
$1.85

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
LNN
LNN
Cash + ST InvestmentsLiquidity on hand
$22.8M
$199.6M
Total DebtLower is stronger
$115.2M
Stockholders' EquityBook value
$275.1M
$518.2M
Total Assets
$587.7M
$828.4M
Debt / EquityLower = less leverage
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
LNN
LNN
Q1 26
$22.8M
Q4 25
$22.7M
$199.6M
Q3 25
$25.6M
$250.6M
Q2 25
$31.2M
$210.8M
Q1 25
$22.1M
$186.7M
Q4 24
$19.2M
$194.1M
Q3 24
$21.5M
$190.9M
Q2 24
$17.7M
$152.7M
Total Debt
CLB
CLB
LNN
LNN
Q1 26
Q4 25
$110.3M
$115.2M
Q3 25
$114.1M
$115.3M
Q2 25
$124.6M
$115.3M
Q1 25
$124.4M
$115.4M
Q4 24
$126.1M
$115.4M
Q3 24
$139.9M
$115.5M
Q2 24
$147.6M
$115.5M
Stockholders' Equity
CLB
CLB
LNN
LNN
Q1 26
$275.1M
Q4 25
$266.0M
$518.2M
Q3 25
$271.3M
$532.9M
Q2 25
$261.3M
$528.8M
Q1 25
$253.4M
$516.4M
Q4 24
$246.6M
$488.5M
Q3 24
$250.7M
$480.9M
Q2 24
$240.3M
$480.0M
Total Assets
CLB
CLB
LNN
LNN
Q1 26
$587.7M
Q4 25
$584.0M
$828.4M
Q3 25
$591.4M
$840.8M
Q2 25
$602.1M
$840.9M
Q1 25
$591.5M
$814.2M
Q4 24
$585.1M
$771.0M
Q3 24
$600.5M
$760.2M
Q2 24
$597.8M
$758.1M
Debt / Equity
CLB
CLB
LNN
LNN
Q1 26
Q4 25
0.41×
0.22×
Q3 25
0.42×
0.22×
Q2 25
0.48×
0.22×
Q1 25
0.49×
0.22×
Q4 24
0.51×
0.24×
Q3 24
0.56×
0.24×
Q2 24
0.61×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
LNN
LNN
Operating Cash FlowLast quarter
$4.0M
$-597.0K
Free Cash FlowOCF − Capex
$517.0K
$-15.1M
FCF MarginFCF / Revenue
0.4%
-10.0%
Capex IntensityCapex / Revenue
9.6%
Cash ConversionOCF / Net Profit
0.77×
-0.04×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$62.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
LNN
LNN
Q1 26
$4.0M
Q4 25
$7.9M
$-597.0K
Q3 25
$8.5M
$64.0M
Q2 25
$13.9M
$35.0M
Q1 25
$6.7M
$12.3M
Q4 24
$20.6M
$21.6M
Q3 24
$13.1M
$53.1M
Q2 24
$17.1M
$30.5M
Free Cash Flow
CLB
CLB
LNN
LNN
Q1 26
$517.0K
Q4 25
$5.0M
$-15.1M
Q3 25
$6.5M
$49.8M
Q2 25
$10.4M
$25.7M
Q1 25
$3.9M
$2.5M
Q4 24
$17.4M
$12.5M
Q3 24
$10.4M
$47.7M
Q2 24
$14.3M
$25.8M
FCF Margin
CLB
CLB
LNN
LNN
Q1 26
0.4%
Q4 25
3.6%
-10.0%
Q3 25
4.8%
33.4%
Q2 25
8.0%
15.5%
Q1 25
3.1%
1.4%
Q4 24
13.4%
7.8%
Q3 24
7.7%
31.9%
Q2 24
10.9%
19.3%
Capex Intensity
CLB
CLB
LNN
LNN
Q1 26
Q4 25
2.1%
9.6%
Q3 25
1.5%
9.6%
Q2 25
2.7%
5.6%
Q1 25
2.3%
5.3%
Q4 24
2.5%
5.7%
Q3 24
2.0%
3.6%
Q2 24
2.2%
3.6%
Cash Conversion
CLB
CLB
LNN
LNN
Q1 26
0.77×
Q4 25
1.61×
-0.04×
Q3 25
0.60×
5.92×
Q2 25
1.31×
1.79×
Q1 25
0.46×
Q4 24
2.78×
1.26×
Q3 24
1.12×
4.17×
Q2 24
1.90×
1.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

LNN
LNN

Transferred At Point In Time$133.2M88%
Infrastructure$13.4M9%
Transferred Over Time$8.0M5%

Related Comparisons